Apexigen, Inc. is a biotechnology company based in San Carlos, California, focused on developing innovative immunotherapies for the treatment of cancer. The company specializes in harnessing the power of monoclonal antibodies and other advanced therapeutic modalities to enhance the immune response against tumors. Apexigen's research emphasizes the discovery and optimization of novel drug candidates, aiming to improve patient outcomes through targeted and effective cancer treatments.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

14 Patents

#29 in San Carlos, CA

#5,325 in California

#22,350 in US

#42,333 in the World

San Carlos, CA, United States of America

Apexigen, Inc.

Forward Citations = 57

13 inventors:

Yongke Zhang (13 out of 14 patents)

Weimin Zhu (10 out of 19 patents)

Guo-Liang Yu (9 out of 142 patents)

4. Yaohuang Ke (5 out of 16 patents)

5. Sum Wai Pierre Lee (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apexigen, Inc.. Retrieved from https://idiyas.com/company/apexigen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]